Guanglei Zhuang

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 16

Top Venues

British journal of cancer

Oncogene

Nature communications

The Journal of pathology

Shanghai Jiao Tong University

Vanderbilt University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Shanghai Jiao Tong University

China

Principle Investigator :: School of Medicine

Genentech Inc

United States

Postdoc Fellow :: Early Drug Discovery

Education History

Vanderbilt University

United States

PHD :: Cancer Biology

Peking University

China

BSC :: School of Life Science

Publications

Lu Zhang, Ruiyun Zhang, Di Jin, Tianxiang Zhang, Akezhouli Shahatiaili, Jingyu Zang, Lu Wang, Yuanchun Pu, Guanglei Zhuang, Haige Chen, Jinhai Fan
Synergistic induction of tertiary lymphoid structures by chemoimmunotherapy in bladder cancer. British journal of cancer 130 (7) (2024)
Lu Zhang, Ruiyun Zhang, Di Jin, Tianxiang Zhang, Akezhouli Shahatiaili, Jingyu Zang, Lu Wang, Yuanchun Pu, Guanglei Zhuang, Haige Chen, Jinhai Fan
Synergistic induction of tertiary lymphoid structures by chemoimmunotherapy in bladder cancer. British journal of cancer 130 (7) (2024)
Lu Zhang, Ruiyun Zhang, Di Jin, Tianxiang Zhang, Akezhouli Shahatiaili, Jingyu Zang, Lu Wang, Yuanchun Pu, Guanglei Zhuang, Haige Chen, Jinhai Fan
Synergistic induction of tertiary lymphoid structures by chemoimmunotherapy in bladder cancer. British journal of cancer (2024)
Ning-Xiang Shen, Ming-Yu Luo, Wei-Ming Gu, Miaomiao Gong, Hui-Min Lei, Ling Bi, Cheng Wang, Mo-Cong Zhang, Guanglei Zhuang, Lu Xu, Liang Zhu, Hong-Zhuan Chen, Ying Shen
GSTO1 aggravates EGFR-TKIs resistance and tumor metastasis via deglutathionylation of NPM1 in lung adenocarcinoma. Oncogene (2024)
Lu Zhang, Ruiyun Zhang, Di Jin, Tianxiang Zhang, Akezhouli Shahatiaili, Jingyu Zang, Lu Wang, Yuanchun Pu, Guanglei Zhuang, Haige Chen, Jinhai Fan
Synergistic induction of tertiary lymphoid structures by chemoimmunotherapy in bladder cancer. British journal of cancer 130 (7) (2024)
Lu Zhang, Ruiyun Zhang, Di Jin, Tianxiang Zhang, Akezhouli Shahatiaili, Jingyu Zang, Lu Wang, Yuanchun Pu, Guanglei Zhuang, Haige Chen, Jinhai Fan
Synergistic induction of tertiary lymphoid structures by chemoimmunotherapy in bladder cancer. British journal of cancer 130 (7) (2024)
Ning-Xiang Shen, Ming-Yu Luo, Wei-Ming Gu, Miaomiao Gong, Hui-Min Lei, Ling Bi, Cheng Wang, Mo-Cong Zhang, Guanglei Zhuang, Lu Xu, Liang Zhu, Hong-Zhuan Chen, Ying Shen
GSTO1 aggravates EGFR-TKIs resistance and tumor metastasis via deglutathionylation of NPM1 in lung adenocarcinoma. Oncogene 43 (33) (2024)
Ning-Xiang Shen, Ming-Yu Luo, Wei-Ming Gu, Miaomiao Gong, Hui-Min Lei, Ling Bi, Cheng Wang, Mo-Cong Zhang, Guanglei Zhuang, Lu Xu, Liang Zhu, Hong-Zhuan Chen, Ying Shen
GSTO1 aggravates EGFR-TKIs resistance and tumor metastasis via deglutathionylation of NPM1 in lung adenocarcinoma. Oncogene 43 (33) (2024)
Xiaoran Long, Huaiwu Lu, Mei-Chun Cai, Jingyu Zang, Zhuqing Zhang, Jie Wu, Xiaoshi Liu, Lin Cheng, Jiejun Cheng, Lydia W T Cheung, Zhen Shen, Ying Zhou, Wen Di, Guanglei Zhuang, Xia Yin
APOBEC3B stratifies ovarian clear cell carcinoma with distinct immunophenotype and prognosis. British journal of cancer (2023)
Jingyu Zang, Ruiyun Zhang, Di Jin, Feng Xie, Akezhouli Shahatiaili, Guangyu Wu, Yue Zhang, Zhixin Zhao, Pan Du, Shidong Jia, Haige Chen, Guanglei Zhuang
Integrated longitudinal circulating tumor DNA profiling predicts immunotherapy response of metastatic urothelial carcinoma in the POLARIS-03 trial. The Journal of pathology (2023)
Lingling Wu, Xiaochuan Hong, Chao Yang, Yuanqin Yang, Wenwen Li, Lu Lu, Meichun Cai, Dongqing Cao, Guanglei Zhuang, Liufu Deng
Noncanonical MAVS signaling restrains dendritic cell-driven antitumor immunity by inhibiting IL-12. Science immunology 8 (90) (2023)
Zhaojuan Yang, Guiqin Xu, Boshi Wang, Yun Liu, Li Zhang, Tiantian Jing, Ming Tang, Xiaoli Xu, Kun Jiao, Lvzhu Xiang, Yujie Fu, Daoqiang Tang, Xiaoren Zhang, Wei-Lin Jin, Guanglei Zhuang, Xiaojing Zhao, Yongzhong Liu
USP12 downregulation orchestrates a protumourigenic microenvironment and enhances lung tumour resistance to PD-1 blockade. Nature communications 12 (1) (2021)
Ying Jing, Jin Liu, Youqiong Ye, Lei Pan, Hui Deng, Yushu Wang, Yang Yang, Lixia Diao, Steven Hsesheng Lin, Gordon B Mills, Guanglei Zhuang, Xinying Xue, Leng Han
Multi-omics prediction of immune-related adverse events during checkpoint immunotherapy. Nature communications 11 (1) (2020)
Kaixuan Shi, Xia Yin, Mei-Chun Cai, Ying Yan, Chenqiang Jia, Pengfei Ma, Shengzhe Zhang, Zhenfeng Zhang, Zhenyu Gu, Meiying Zhang, Wen Di, Guanglei Zhuang
PAX8 regulon in human ovarian cancer links lineage dependency with epigenetic vulnerability to HDAC inhibitors. eLife 8 (2019)
Ying Jing, Ruiyun Zhang, Pengfei Ma, Mei-Chun Cai, Guanglei Zhuang, Haige Chen
Prevalence and clonality of synchronous primary carcinomas in the bladder and prostate. The Journal of pathology 244 (1) (2018)
Shengzhe Zhang, Meiying Zhang, Ying Jing, Xia Yin, Pengfei Ma, Zhenfeng Zhang, Xiaojie Wang, Wen Di, Guanglei Zhuang
Deubiquitinase USP13 dictates MCL1 stability and sensitivity to BH3 mimetic inhibitors. Nature communications 9 (1) (2018)

Guanglei Zhuang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Guanglei Zhuang